ESMO: European Society for Medical Oncology

  1. Evidence for efficacy is based on the results from the TITAN trial
  2. Combination treatment concerns patients with advanced endometrial carcinoma who progressed on prior systemic treatment and whose tumours are not MSI-H or dMMR
  3. An electronic nose that detects chemicals in the breath of lung cancer patients can identify with 85% accuracy those who will or will not respond to immunotherapy, according to new research published in the leading cancer journal Annals of Oncology today.
  4. Doxolipad, a hybrid medicine, contains the active substance doxorubicin
  5. The next research and innovation framework programme